Alessandra Ruggiero

Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers.

Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.

Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies.

Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA.

Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human Repeat Sequences.

Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2.

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals.

Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.

Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients.

A Quantitative Method for the Study of HIV-1 and Mycobacterium tuberculosis Coinfection.

HIV and SARS-CoV-2 Co-Infection: From Population Study Evidence to In Vitro Studies.

Subjects who developed SARS-CoV-2 specific IgM after vaccination show a longer humoral immunity and a lower frequency of infection.